A Review of Skin Banking Guidelines and Standards Worldwide: Towards the Harmonization of Guidelines for Skin Banking in Therapeutic Applications for the Regions under the Asia Pacific Burn Association (APBA)

Abstract

Currently, there are no harmonized guidelines which govern skin banking in the Asia Pacific region. Therefore, skin banks are either unregulated or rely on their nation’s legislation or international accreditation to uphold their quality standards. A new set of skin banking guidelines was developed through a comprehensive review and collation of best international practices for the Asia Pacific Burn Association (APBA) members, from donor screening and testing, to skin recovery, processing, storage and distribution, and quality assurance. National regulatory requirements reviewed include the European directives, Australia’s Therapeutic Goods Administration and Singapore’s tissue banking standards. Further technical and quality management recommendations are referenced from the American Association of Tissue Banks (AATB), the United States Food and Drug Administration standards and guidance documents, various relevant European guides, Japanese Society of Tissue Transplantation guidelines and the Asia Pacific Association of Surgical Tissue Banking. Adapted mainly from the AATB standards, the new Asia Pacific Burn Association Guidelines for Skin Banking in Therapeutic Applications offer a comprehensive manual, addressing: governance and contracts; staff responsibilities; quality management; facilities, equipment and supplies management; donor consent and testing; and recommendations of good practices pertaining to skin recovery, processing, storage and distribution. Besides complementing current generic regulations, they provide technical specifications of major aspects unaddressed in most legislations. This inaugural set of new regional skin banking guidelines would be a start for regional members of the APBA to adopt, and will hopefully culminate in a set of standards so that, in the long run, skin allografts from this region can be of similar quality, which can simplify import process and facilitate the exchange of allografts between members.

Keywords

Skin banking / Skin allografts / Skin transplantation / Tissue banking / Tissue donation

References

[1] Dziewulski P, Wolf SE. The use of allograft skin in burn surgery. In: Warwick RM, Brubaker SA (eds). Tissue and Cell Clinical Use-An Essential Guide. United Kingdom: Wiley-Blackwell, 2012, 236-57.

[2] Carter JE, Holmes JH. The surgical management of burn wounds. In: Albanna M, Holmes JH (eds). Skin Tissue Engineering and Regenerative Medicine. USA: Elsevier Inc. Academic Press, 2016, 289-98.

[3] Voigt CD, Williamson S, Kagan RJ, Branski LK. The skin bank. In: Herndon DN (ed). Total Burn Care, 5th edn. Netherlands: Elsevier Inc, 2018, 158-66.

[4] Strong DM.The contribution of Kenneth W. Sell to the progress of tissue banking. In: Philips GO, Von Versen R, Strong DM, Nather A (eds). Advances in Tissue Banking, Vol. 2. Singapore: World Scientific, 1998, 1-19.

[5] Strong DM. The US Navy tissue bank: 50 years on the cutting edge. Cell Tissue Bank. 2000; 1: 9-16.

[6] Tognetti L, Pianigiani E, Ierardi F, Mariotti G, Perrotti R, Di Lonardo A, et al. Current insights into skin banking: storage, preservation and clinical importance of skin allografts. Journal of Biorepository Science for Applied Medicine. 2017; 5: 41-56.

[7] Joyce MJ. American Association of Tissue Banks-the present and future. In: Philips GO, Von Versen R, Strong DM, Nather A (eds). Advances in Tissue Banking, Vol. 2. Singapore: World Scientific, 1998, 29-35.

[8] Fragale DA. Regulatory models for safety and quality of allografts: USA (heart valves). In: Philips GO, Von Versen R, Strong DM, Nather A (eds). Advances in Tissue Banking, Vol. 1. Singapore: World Scientific, 1997, 13-21.

[9] Tissue & Tissue Products. Available at: https://www.fda.gov/vaccines-blood-biologics/tissue-tissue-products. 2019 Accessed 3 Jun 2019.

[10] FDA Regulation of Human Cells and Tissues. Available at: http://www.fda.gov/media/81676/download. Accessed 30 May 2019.

[11] US Department of Health and Human Services, Office of Inspector General-Oversight of Tissue Banking. Available at: http://www.hhs.gov/oig/oei. 2001 Accessed 10 Jun 2019.

[12] CFR-Code of Federal Regulations Title 21. Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=1271. 2019 Accessed 30 May 2019.

[13] 42 U.S.C. §264. Regulations to Control Communicable Diseases Available at: https://www.govinfo.gov/content/pkg/USCODE-2011-title42/html/USCODE-2011-title42-chap6A-subchapII-partG.htm. 2011 Accessed 24 Sep 2019.

[14] FDA Regulation of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/P’s) Product List. Available at: https://www.fda.gov/vaccines-blood-biologics/tissue-tissue-products/fda-regulation-human-cells-tissues-and-cellular-and-tissue-based-products-hctps-product-list. 2018 Accessed 30 May 2019.

[15] Human Cells, Tissues, and Cellular and Tissue-Based Products; Donor Screening and Testing, and Related Labeling. Available at: https://www.federalregister.gov/documents/2007/06/19/E7-11795/human-cells-tissues-and-cellular-and-tissue-based-products-donor-screening-and-testing-and-related. 2007 Accessed 30 May 2019.

[16] Eligibility Determination of Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products. Available at: https://www.federalregister.gov/documents/2004/05/25/04-11245/eligibility-determination-for-donors-of-human-cells-tissues-and-cellular-and-tissue-based-products. 2004 Accessed 30 May 2019.

[17] Current Good Tissue Practice for Human Cell, Tissue, and Cellular and Tissue-Based Product Establishments; Inspection and Enforcement. Available at: https://www.federalregister.gov/documents/2004/11/24/04-25798/current-good-tissue-practice-for-human-cell-tissue-and-cellular-and-tissue-based-product. 2004 Accessed 30 May 2019.

[18] Human Cells, Tissues, and Cellular and Tissue-Based Products; Establishment Registration and Listing. Available at: https://www.federalregister.gov/documents/ 2001/01/19/01-1126/human-cells-tissues-and-cellular-and-tissue-based-products-establishment-registration-and-listing. 2001 Accessed 30 May 2019.

[19] Guidance for Industry-Current Good Tissue Practice (CGTP) and Additional Requirements for Manufacturers of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps). Available at: https://www.fda.gov/media/82724/download. 2011 Accessed 30 May 2019.

[20] Guidance for Industry-Eligibility Determination for Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps). Available at: https://www.fda.gov/media/73072/download. 2007 Accessed 30 May 2019.

[21] Guidance for Industry: Investigating and Reporting Adverse Reactions Related to Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) Regulated Solely under Section 361 of the Public Health Service Act and 21 CFR Part 1271. Available at: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/investigating-and-reporting-adverse-reactions-related-human-cells-tissues-and-cellular-and-tissue. 2016 Accessed 30 May 2019.

[22] Guidance Document-Deviation Reporting for Human Cells, Tissues, and Cellular and Tissue-Based Products Regulated Solely Under Section 361 of the Public Health Service Act and 21 CFR Part 1271. Available at: https://www.fda.gov/media/107703/download. 2017 Accessed 30 May 2019.

[23] Brubaker SA, Fehily D. Development of vigilance and surveillance systems. In: Warwick RM, Brubaker SA (eds). Tissue and Cell Clinical Use-An Essential Guide. USA: Wiley-Blackwell, 2012, 48-71.

[24] Joyce MJ. American Association of Tissue Banks: a historical reflection upon entering the 21st century. Cell Tissue Bank. 2000; 1: 5-8.

[25] Brubaker SA.Establishing a quality system. In: Galea G (ed). Essentials of Tissue Banking. Netherlands: Springer Science & Business Media, 2010, 191-215.

[26] American Association of Tissue Banks.Standards for Tissue Banking, 14th edn. 2016.

[27] AATB Non-transplant Anatomical Donation Organizations (NADOs) Guidance Documents. Available from: https://www.aatb.org/standards/nado-guidance-documents. Accessed 24 Sep 2019.

[28] Cells, Tissues and Organs. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/information-health-product/cells-tissues-organs.html. Accessed 7 Jun 2019.

[29] Profile Page for Guidance Document for Cell, Tissue and Organ Establishments-Safety of Human Cells, Tissues and Organs for Transplantation. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/regulatory-initiatives/cells-tissues-organs/guidance-document-safety-human-cells-tissues-organs-transplantation.html. Accessed 7 Jun 2019.

[30] Guidance Document for Cell, Tissue and Organ Establishments, Safety of Human Cells, Tissues and Organs for Transplantation. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/regulatory-initiatives/cells-tissues-organs/guidance-document-safety-human-cells-tissues-organs-transplantation/document.html. Accessed 7 Jun 2019.

[31] Guidance Document for Source Establishments-Reporting Adverse Reactions to Human Cells, Tissues and Organs. Available from: https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/reporting-adverse-reactions-human-cells-tissues-organs.html. Accessed 7 Jun 2019.

[32] Final report / Commissioner: Horace Krever Available from: http://publications.gc.ca/site/eng/9.646740/publication.html. Accessed 19 Sep 2019.

[33] The Evolution of Eye Banking and Regulatory Standards in Canada Available from: http://eyebankingjournal.org/wp-content/uploads/2015/12/53-1040-1-PB.pdf. Accessed 19 Sep 2019.

[34] Therapeutic Goods Administration.Australian Code of Good Manufacturing Practice for Human Blood and Blood Components, Human Tissues and Human Cellular Therapy Products, version 1.0; April 2013. https://www.tga.gov.au/sites/default/files/manuf-cgmp-human-blood-tissues-2013.pdf. Accessed 12 Jun 2019.

[35] Wright C, Velickovic Z, Brown R, Larsen S, MacPherson JL, Gibson J, et al. Raising the standard: changes to the Australian code of Good Manufacturing Practice (cGMP) for human blood and blood components, human tissues and human cellular therapy products. Pathology. 2014; 46: 177-83.

[36] Therapeutic Goods (Manufacturing Principles) Determination 2018. Available from: https://www.legislation.gov.au/Details/F2017L01574. Accessed 12 Jun 2019.

[37] Therapeutic Goods Order No. 86-Standards for Human Skin (08/07/2011). Available from: https://www.legislation.gov.au/Details/F2011L01492. Accessed 12 Jun 2019.

[38] Therapeutic Goods Order No. 88-Standards for donor selection, testing, and minimising infectious disease transmission via therapeutic goods that are human blood and blood components, human tissues and human cellular therapy products. Available from: https://www.legislation.gov.au/Details/F2013L00854. Accessed 12 Jun 2019.

[39] History of the European Association of Tissue Banks (EATB) Available from: https://www.eatb.org/images/pdf/1.3history_of_eatb.pdf. Accessed 31 May 2019.

[40] Monig HJ, Versen RV. Standards, Regulatory and Quality Systems, Within a Global Context. In: Philips GO, editor. Radiation and Tissue Banking (IAEA). World Scientific. 2000. p. 1-55.

[41] Freelander E, Boyce S, Ghosh M, Ralston DR, MacNeil S. Skin banking in the UK: the need for proper organisation. Burns 1998; 24: 19-24.

[42] Human Tissue Authority-Guidance for Professionals. Available from: https://www.hta.gov.uk/guidance-professionals. Accessed 24 Sep 2019.

[43] Marazuela R, Garrido G, Matesanz R. European Union and Spanish regulations on quality and safety of tissues and cells: overview and biovigilance. Transplant Proc 2009; 41: 2044-6.

[44] European Union.EU Tissue and Cells Directives. Available from: https://www.hta.gov.uk/policies/eu-tissue-and-cells-directives. Accessed 10 Jun 2019.

[45] European Union.Directive 2004/23/EC of the European Parliament and of the Council of 31 March 2004 on setting standards of quality and safety for the donation, procurement, testing, processing, preservation, storage and distribution of human tissues and cells. Available from: https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2004:102:0048:0058:en:PDF. Accessed 10 Jun 2019.

[46] European Union.Commission Directive 2006/17/EC of 8 February 2006 implementing Directive 2004/23/EC of the European Parliament and of the Council as regards certain technical requirements for the donation, procurement and testing of human tissues and cells Available from: https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2006:038:0040:0052:EN:PDF. Accessed 10 Jun 2019.

[47] European Union.Commission Directive 2006/86/EC of 24 October 2006 implementing Directive 2004/23/EC of the European Parliament and of the Council as regards traceability requirements, notification of serious adverse reactions and events and certain technical requirements for the coding, processing, preservation, storage and distribution of human tissues and cells. Available from: https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2006:294:0032:0050:EN:PDF Accessed 10 Jun 2019.

[48] European Union.Commission Directive 2012/39/EU of 26 November 2012 amending Directive 2006/17/EC as regards certain technical requirements for the testing of human tissues and cells. Available from: https://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2012:327:0024:0025:en:PDF. Accessed 10 Jun 2019.

[49] European Union.Commission Directive (EU) 2015/565 of 8 April 2015 amending Directive 2006/86/EC as regards certain technical requirements for the coding of human tissues and cells. Available from: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32015L0565&from=EN. Accessed 10 Jun 2019.

[50] European Union.Commission Directive (EU) 2015/566 of 8 April 2015 implementing Directive 2004/23/EC as regards the procedures for verifying the equivalent standards of quality and safety of imported tissues and cells Available from: https://www.legislation.gov.uk/eudr/2015/566/pdfs/eudr_20150566_2015-04-08_en.pdf. Accessed 10 Jun 2019.

[51] Kaminski A, Uhrynowska-Tyszkiewicz I, Miranda B. Design and validation of a specialised training model for tissue bank personnel as a result of the European quality system for tissue banking (EQSTB) project. Transplant Proc. 2007; 39: 2698-700.

[52] Europe Directorate for the Quality of Medicines & Healthcare (EDQM); Council of Europe.Guide to the Quality and Safety of Tissues and Cells for Human Application, 4th edn. September 2019. https://www.edqm.eu/en/organs-tissues-and-cells-technical-guides. Accessed 10 Jun 2019.

[53] Euro-GTP II Guide: Good Practices for evaluating quality, safety and efficacy of novel tissue and cellular therapies and products. Available from: http://www.goodtissuepractices.site/docs/EuroGTP_II_Guide.pdf. Accessed 11 Jun 2019.

[54] European Union Standards and Training for the Inspection of Tissues Establishments (EUSTITE). Available from: https://www.notifylibrary.org/content/european-union-standards-and-training-inspection-tissue-establishments-project-eustite. Accessed 11 Jun 2019.

[55] SOHO V&S Guidance for Competent Authorities: Communication and Investigation of Serious Adverse Events and Reactions Associated with Human Tissues and Cells. Available from: https://www.notifylibrary.org/sites/default/files/SOHO%20V%26S%20Communication%20and%20Investigation%20Guidance.pdf. Accessed 11 Jun 2019.

[56] Vigilance and Surveillance of Substances of Human Origin (SOHO V&S), SOHO V&S Guidance for Healthcare Professionals on Vigilance and Surveillance of Human Tissues and Cells. Available from: https://www.notifylibrary.org/sites/default/files/SOHOV%26S%20Vigilance%20Guidance%20for%20Healthcare%20Professionals%20-%20Part%201%20Tissues_0.pdf. Accessed 11 Jun 2019.

[57] Pedraza JM, Gajiwala AL, Pardo MEM. A review of the International Atomic Energy Agency (IAEA) international standards for tissue banks. Cell Tissue Bank. 2012; 13: 15-25.

[58] ISO 9000 Family-Quality Management. Available from: https://www.iso.org/iso-9001-quality-management.html. Accessed 24 May 2019.

[59] Du Pont JS. Regulatory Models for Safety and Quality of Allografts: Europe. In: Philips GO, von Versen R, Strong DM, Nather A (eds). Advances in Tissue Banking, Vol. volume 1. Singapore: World Scientific, 1997, 3-12.

[60] World Health Organization.Aide-Memoire on Key Safety Requirements For Essential Minimally Processed Human Cells and Tissues for Transplantation. Available from: https://www.who.int/transplantation/AM_HCTTmin_requirements.pdf. Accessed 27 Jun 2019.

[61] World Health Organization.Resolution WHA63.22 Human Organ and Tissue Transplantation. Available from: http://apps.who.int/gb/ebwha/pdf_files/WHA63/A63_R22-en.pdf. Accessed 27 Jun 2019.

[62] Biller-Andorno N, Wilson D, Kerridge I, Chapman JR. Ethical issues regarding the use of human tissues and cells. In: Warwick RM, Brubaker SA (eds). Tissue and Cell Clinical Use-An Essential Guide. USA: Wiley-Blackwell, 2012, 1-22.

[63] Nather A, Foong SYM, Tan N, Wang K. Tissue banking in Asia Pacific region-past, present and future. Cell Tissue Bank. 2018; 19: 229-40.

[64] Ministry of Health Singapore (2003) Guidelines for Healthcare Institutions Providing Tissue Banking: Regulation 4 of the Private Hospitals and Medical Clinics Regulations (CAP 248, RG 1). Available from: https://www.moh.gov.sg/docs/librariesprovider5/licensing-terms-and-conditions/guidelines-for-private-healthcare-institutions-providing-tissue-banking.pdf. Accessed 25 Sep 2019.

[65] Gajiwala AL. Regulatory aspects of tissue donation, banking and transplantation in India. Cell Tissue Bank. 2018; 19: 241-8.

[66] Sahay M.Transplantation of human organs and tissues act-“simplified”. Indian Journal of Transplantation. 2018; 12: 84-9.

[67] Korean’s Safety, Management, etc. of Human Tissue Act. Available from: http://www.moleg.go.kr/english/korLawEng?pstSeq=58339&brdSeq=33&searchCondition=AIIButCsfCd&searchKeyword=urba. Accessed 7 Jun 2019.

[68] Aktar N, Rahman MS, Jamil HM, Arifuzzaman M, Miah MM, Asaduzzaman SM. Tissue banking in Bangladesh: 12 years of experience (2003-2014). Cell Tissue Bank. 2016; 17: 189-97.

[69] Japan Society of Tissue Transplantation.Guideline on the Safety, Storage, and Application of Human Tissue in Medical Practice. Available from: http://www.jstt.org/htm/topics/Safety.pdf.Accessed27Jun2019.

[70] Japan Society of Tissue Transplantation.Guideline on Ethical Issues in Application of Human Tissue to Medical Practice. Available from: http://www.jstt.org/htm/topics/Ethical.pdf. Accessed 27 Jun 2019.

[71] Japan Society of Tissue Transplantation.Basic Standards for Operating A Human Tissue Bank & Quality Assessment Form. Available from: http://www.jstt.org/htm/topics/Standards.pdf. Accessed 27 Jun 2019.

[72] Heng WL, Heng WL, Seck T, Tay CP, Chua A, Song C, et al. Homograft banking in Singapore: two years of cardiovascular tissue banking in Southeast Asia. Cell Tissue Bank. 2013; 14: 187-94.

[73] Kitchen A, Barbara J. Testing the donor. In: Galea G (ed). Essentials of Tissue Banking. Springer Science & Business Media, Netherlands, 2010, 141-65.

[74] American Association of Tissue Banks.Standards for Tissue Banking, Netherlands, 12th edn, 2008.

[75] American Association of Tissue Banks.Standards for Tissue Banking, 13th edn, 2012.

[76] European Centre for Disease Prevention and Control.Technical Report: Geographical distribution of areas with high prevalence of HTLV-1 infection. Available from: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/geographical-distribution-areas-high-prevalence-HTLV1.pdf. Accessed 27 Jun 2019.

[77] Eid AJ, Brown RA, Patel R, Razonable RR. Parvovirus B19 infection after transplantation: a review of 98 cases. Clin Infect Dis. 2006; 43: 40-8.

[78] Darrigo LG, Carvalho AM, Machado CM. Chikungunya, dengue, and Zika in Immunocompromised hosts. Curr Infect Dis Rep. 2018; 20: 5.

[79] Tan LSF, Loh LSKD, Prabhakaran K. Dengue haemorrhagic fever after living donor renal transplantation. Nephrol Dial Transplant. 2005; 20: 447-8.

[80] Cedano JA, Mora BL, Parra-Lara LG, Manzano-Nuñez R, Rosso F, et al. A scoping review of transmission of dengue virus from donors to recipients after solid organ transplantation. Trans R Soc Trop Med Hyg. 2019. https://doi.org/10.1093/trstmh/trz024 (Epub ahead of print).

[81] Tambyah PA. Dengue haemorrhagic fever transmitted by blood transfusion. N Engl J Med. 2008; 359: 1526-7.

[82] Musso D, Gubler DJ. Zika virus. Clin Microbiol Rev. 2016; 29: 487-524.

[83] Eastlund T, Winters MK. Testing the Tissue and the Environment. In: Galea G (ed). Essentials of Tissue Banking. Springer Science+Business Media; 2010. p. 167-187.